MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $39.6 million versus the consensus estimate of $38.15 million. MiMedx Group reaffirmed FY2015 guidance.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.